| Factors associated with death in critically ill patients with coronavirus disease 2019 in the US S Gupta, SS Hayek, W Wang, L Chan, KS Mathews, ML Melamed, ... JAMA internal medicine 180 (11), 1436-1447, 2020 | 945 | 2020 |
| Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19 S Gupta, W Wang, SS Hayek, L Chan, KS Mathews, ML Melamed, ... JAMA internal medicine 181 (1), 41-51, 2021 | 512 | 2021 |
| Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic AM South, L Tomlinson, D Edmonston, S Hiremath, MA Sparks Nature Reviews Nephrology 16 (6), 305-307, 2020 | 325 | 2020 |
| Characteristics and outcomes of individuals with pre-existing kidney disease and COVID-19 admitted to intensive care units in the United States JE Flythe, MM Assimon, MJ Tugman, EH Chang, S Gupta, J Shah, ... American Journal of Kidney Diseases 77 (2), 190-203. e1, 2021 | 248 | 2021 |
| Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial JB Cohen, TC Hanff, P William, N Sweitzer, NR Rosado-Santander, ... The lancet respiratory medicine 9 (3), 275-284, 2021 | 231 | 2021 |
| FGF23 at the crossroads of phosphate, iron economy and erythropoiesis D Edmonston, M Wolf Nature Reviews Nephrology 16 (1), 7-19, 2020 | 181 | 2020 |
| Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States MZ Molnar, A Bhalla, A Azhar, M Tsujita, M Talwar, V Balaraman, A Sodhi, ... American Journal of Transplantation 20 (11), 3061-3071, 2020 | 113 | 2020 |
| Medical management of heart failure with reduced ejection fraction in patients with advanced renal disease AM Hein, JJ Scialla, D Edmonston, LB Cooper, AD DeVore, RJ Mentz JACC: Heart Failure 7 (5), 371-382, 2019 | 50 | 2019 |
| Pulmonary hypertension subtypes and mortality in CKD DL Edmonston, KS Parikh, S Rajagopal, LK Shaw, D Abraham, A Grabner, ... American Journal of Kidney Diseases 75 (5), 713-724, 2020 | 43 | 2020 |
| Design and rationale of HiLo: a pragmatic, randomized trial of phosphate management for patients receiving maintenance hemodialysis DL Edmonston, T Isakova, LM Dember, S Brunelli, A Young, R Brosch, ... American Journal of Kidney Diseases 77 (6), 920-930. e1, 2021 | 35 | 2021 |
| Kidney recovery and death in critically ill patients with COVID-19–associated acute kidney injury treated with dialysis: the STOP-COVID cohort study CM Hsu, S Gupta, H Tighiouart, N Goyal, AJ Faugno, A Tariq, ... American journal of kidney diseases 79 (3), 404-416. e1, 2022 | 34 | 2022 |
| Identification of distinct clinical subphenotypes in critically ill patients with COVID-19 CR Vasquez, S Gupta, TA Miano, M Roche, J Hsu, W Yang, DN Holena, ... Chest 160 (3), 929-943, 2021 | 32 | 2021 |
| Infection rate and risk factor analysis in an orthopaedic ambulatory surgical center. DL Edmonston, GD Foulkes Journal of surgical orthopaedic advances 19 (3), 174-176, 2010 | 32 | 2010 |
| Association of post-discharge specialty outpatient visits with readmissions and mortality in high-risk heart failure patients DL Edmonston, J Wu, RA Matsouaka, C Yancy, P Heidenreich, IL Piña, ... American heart journal 212, 101-112, 2019 | 30 | 2019 |
| Randomized elimination and prolongation of ACE inhibitors and ARBs in coronavirus 2019 (REPLACE COVID) Trial Protocol JB Cohen, TC Hanff, V Corrales‐Medina, P William, N Renna, ... The Journal of Clinical Hypertension 22 (10), 1780-1788, 2020 | 18 | 2020 |
| Coronavirus disease 2019 and hypertension: the role of angiotensin-converting enzyme 2 and the renin-angiotensin system DL Edmonston, AM South, MA Sparks, JB Cohen Advances in chronic kidney disease 27 (5), 404-411, 2020 | 18 | 2020 |
| Single measurements of carboxy-terminal fibroblast growth factor 23 and clinical risk prediction of adverse outcomes in CKD D Edmonston, D Wojdyla, R Mehta, X Cai, C Lora, D Cohen, ... American Journal of Kidney Diseases 74 (6), 771-781, 2019 | 17 | 2019 |
| Obesity, inflammatory and thrombotic markers, and major clinical outcomes in critically ill patients with COVID‐19 in the US AN Friedman, J Guirguis, R Kapoor, S Gupta, DE Leaf, LR Timsina, ... Obesity 29 (10), 1719-1730, 2021 | 15 | 2021 |
| Performance of crisis standards of care guidelines in a cohort of critically ill COVID-19 patients in the United States JL Jezmir, M Bharadwaj, A Chaitoff, B Diephuis, CP Crowley, SP Kishore, ... Cell Reports Medicine 2 (9), 2021 | 14 | 2021 |
| The emerging role of novel antihyperglycemic agents in the treatment of heart failure and diabetes: a focus on cardiorenal outcomes KR McHugh, AD DeVore, RJ Mentz, D Edmonston, JB Green, ... Clinical Cardiology 41 (9), 1259-1267, 2018 | 14 | 2018 |
